These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 32534589)

  • 1. ε2 allele and ε2-involved genotypes (ε2/ε2, ε2/ε3, and ε2/ε4) may confer the association of APOE genetic polymorphism with risks of nephropathy in type 2 diabetes: a meta-analysis.
    Shi J; Cheng Z; Qiu S; Cui H; Gu Y; Zhao Q; Ren Y; Zhang H; Sun H; Liu Y; Li Y; Qiao Y; Hu Y; Liu Y; Cheng Y
    Lipids Health Dis; 2020 Jun; 19(1):136. PubMed ID: 32534589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E genetic polymorphism influence the susceptibility to nephropathy in type 2 diabetes patients.
    Atageldiyeva KK; Nemr R; Echtay A; Racoubian E; Sarray S; Almawi WY
    Gene; 2019 Oct; 715():144011. PubMed ID: 31357022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between apolipoprotein E gene polymorphism and mild cognitive impairment: a meta-analysis.
    Jiang Y; He T; Deng W; Sun P
    Clin Interv Aging; 2017; 12():1941-1949. PubMed ID: 29180857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between ApoE Polymorphism and Type 2 Diabetes: A Meta-Analysis of 59 Studies.
    Chen DW; Shi JK; Li Y; Yang Y; Ren SP
    Biomed Environ Sci; 2019 Nov; 32(11):823-838. PubMed ID: 31910940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of apolipoprotein E gene polymorphism on development of type 2 diabetes mellitus in Chinese Han population: a meta-analysis of 29 studies.
    Yin YW; Qiao L; Sun QQ; Hu AM; Liu HL; Wang Q; Hou ZZ
    Metabolism; 2014 Apr; 63(4):532-41. PubMed ID: 24439487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated meta-analysis of the role of APOE ε2/ε3/ε4 alleles in frontotemporal lobar degeneration.
    Su WH; Shi ZH; Liu SL; Wang XD; Liu S; Ji Y
    Oncotarget; 2017 Jul; 8(27):43721-43732. PubMed ID: 28487499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between ApoE polymorphism and hypertension: A meta-analysis of 28 studies including 5898 cases and 7518 controls.
    Shi J; Liu Y; Liu Y; Li Y; Qiu S; Bai Y; Gu Y; Luo J; Cui H; Li Y; Zhao Q; Zhang K; Cheng Y
    Gene; 2018 Oct; 675():197-207. PubMed ID: 30180966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis.
    Chen Q; Wang T; Kang D; Chen L
    Sci Rep; 2022 Aug; 12(1):13620. PubMed ID: 35948759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
    Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
    Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E polymorphism and expression in type 2 diabetic patients with nephropathy: clinicopathological correlation.
    Guan J; Zhao HL; Baum L; Sui Y; He L; Wong H; Lai FM; Tong PC; Chan JC
    Nephrol Dial Transplant; 2009 Jun; 24(6):1889-95. PubMed ID: 19218599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of the association between Apolipoprotein E polymorphism and risks of myocardial infarction.
    Shao A; Shi J; Liang Z; Pan L; Zhu W; Liu S; Xu J; Guo Y; Cheng Y; Qiao Y
    BMC Cardiovasc Disord; 2022 Mar; 22(1):126. PubMed ID: 35331149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Associations between Apolipoprotein E Gene Epsilon2/Epsilon3/Epsilon4 Polymorphisms and the Risk of Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus.
    Luo JQ; Ren H; Banh HL; Liu MZ; Xu P; Fang PF; Xiang DX
    Front Physiol; 2017; 8():1031. PubMed ID: 29311965
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.
    Farrer LA; Cupples LA; Haines JL; Hyman B; Kukull WA; Mayeux R; Myers RH; Pericak-Vance MA; Risch N; van Duijn CM
    JAMA; 1997 Oct 22-29; 278(16):1349-56. PubMed ID: 9343467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between lipid metabolism gene polymorphisms and nephropathy in type 2 diabetes: a meta-analysis.
    Li T; Shi Y; Yin J; Qin Q; Wei S; Nie S; Liu L
    Int Urol Nephrol; 2015 Jan; 47(1):117-30. PubMed ID: 25262148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis.
    Agarwal R; Tripathi CB
    Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):575-82. PubMed ID: 25551132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOE polymorphism and diabetic nephropathy.
    Araki S
    Clin Exp Nephrol; 2014 Apr; 18(2):230-3. PubMed ID: 24026386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of APOE ε2/ε3/ε4 polymorphism and cerebral infarction.
    Wang QY; Wang WJ; Wu L; Liu L; Han LZ
    J Neural Transm (Vienna); 2013 Oct; 120(10):1479-89. PubMed ID: 23571734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of apolipoprotein E (APOE) gene polymorphisms with atherosclerosis susceptibility: a meta-analysis.
    Zhu H; Xue H; Wang H; Ma Y; Liu J; Chen Y
    Minerva Cardioangiol; 2016 Feb; 64(1):47-54. PubMed ID: 26005211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE polymorphism and the progression of diabetic nephropathy in Japanese subjects with type 2 diabetes: results of a prospective observational follow-up study.
    Araki S; Koya D; Makiishi T; Sugimoto T; Isono M; Kikkawa R; Kashiwagi A; Haneda M
    Diabetes Care; 2003 Aug; 26(8):2416-20. PubMed ID: 12882872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of the apolipoprotein E gene polymorphism Turkish Type 2 diabetic patients with and without nephropathy.
    Erdogan M; Eroglu Z; Biray C; Karadeniz M; Cetinkalp S; Kosova B; Gunduz C; Topcuoglu N; Ozgen G; Yilmaz C
    J Endocrinol Invest; 2009 Mar; 32(3):219-22. PubMed ID: 19542737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.